Phase 3 HD Clinical Trials
29 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–20 of 29 trials
Recruiting
Phase 3
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
Growth Hormone Deficiency (GHD)
Lumos Pharma150 enrolled42 locationsNCT06948214
Recruiting
Phase 3
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder
Cannabis withdrawal
PleoPharma, Inc.420 enrolled17 locationsNCT07644052
Recruiting
Phase 3
GB06 Phase III Trial for Pediatric Growth Hormone Deficiency
Growth Hormone Deficiency (GHD)Growth Hormone Deficiency in ChildrenGrowth Hormone Deficiency, Pediatric
Kexing Biopharm Co., Ltd.192 enrolled1 locationNCT07553351
Recruiting
Phase 3
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
facioscapulohumeral muscular dystrophyFascioscapulohumeral Muscular DystrophyFacio-Scapulo-Humeral Dystrophy+14 more
Avidity Biosciences, Inc.200 enrolled46 locationsNCT07038200
Recruiting
Phase 3
Safety and Efficacy of Iguratimod in the Treatment of Chronic GVHD
cGVHD
Xuzhou Medical University20 enrolled1 locationNCT06244628
Recruiting
Phase 3
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Graft-Versus-Host-Disease (GVHD)
Incyte Corporation572 enrolled30 locationsNCT06615050
Recruiting
Phase 3
Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor
GvHD
Assistance Publique - Hôpitaux de Paris324 enrolled28 locationsNCT06083129
Recruiting
Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Opioid UseOpioid-use DisorderWithdrawal Symptoms
Emory University103 enrolled6 locationsNCT05834478
Recruiting
Phase 3
Benefits of ADHD Treatment in Detained People
ADHD
Stéphanie Baggio150 enrolled1 locationNCT05842330
Recruiting
Phase 3
A Long-term Trial of EB-1020 in Pediatric Patients With ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Co., Ltd.180 enrolled1 locationNCT07087327
Recruiting
Phase 2Phase 3
A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Co., Ltd.315 enrolled1 locationNCT07086313
Recruiting
Phase 3
Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)
Pregnancy ComplicationsOpioid-use DisorderPregnancy Related+2 more
Washington University School of Medicine40 enrolled1 locationNCT05790252
Recruiting
Phase 3
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
AnxietySocial Anxiety DisorderADHD+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc.308 enrolled47 locationsNCT06973577
Recruiting
Phase 2Phase 3
Effects of Ketone Supplementation on Alcohol Withdrawal and Brain Metabolism in Alcohol Use Disorder
alcohol withdrawalKetosisAlcohol Use Disorder
University of Pennsylvania30 enrolled1 locationNCT06559995
Recruiting
Phase 2Phase 3
Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
Attention Deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Co., Ltd.630 enrolled1 locationNCT06931080
Recruiting
Phase 3
A Long-term Trial of EB-1020 in Adult Patients With ADHD
Attention Deficit Hyperactivity Disorder (ADHD)
Otsuka Pharmaceutical Co., Ltd.180 enrolled1 locationNCT06926829
Recruiting
Phase 3
NO During CPB in Neonates to Reduce Risk of AKI
SurgeryAKICHD - Congenital Heart Disease
Children's Hospital Medical Center, Cincinnati40 enrolled1 locationNCT04216927
Active
Phase 3
A Study to Evaluate Tobevibart+Elebsiran in Chronic Hepatitis Delta Virus (HDV) Infection (ECLIPSE 1)
Chronic Hepatitis Delta Virus (HDV) Infection
Vir Biotechnology, Inc.120 enrolled10 locationsACTRN12625000416493
Recruiting
Phase 3
EEG-MRI Imaging of Methylphenidate Effects in Adult ADHD and Attentional Symptoms in Mood Disorders
Adult ADHDAdult-onset ADHD With Mood Disorder
University Hospital, Strasbourg, France80 enrolled1 locationNCT05832489
Recruiting
Phase 2Phase 3
Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women
DyslipidemiasPostmenopausal SymptomsHypercholesterolemia+3 more
Dhurakij Pundit University10 enrolled1 locationNCT06220266